ゲノムシーケンシングの世界市場レポート 2024年

ゲノムシーケンシング市場規模は、今後数年で急成長が見込まれます。2028年にはCAGR19.1％で198億7,000万米ドルに成長します。予測期間中に予想される成長は、ゲノム研究の進歩、遺伝性疾患の有病率の上昇、がん罹患率の増加、他のオミクスとの統合、一般市民の認識と受容の高まりに起因すると考えられます。この期間を形成すると予想される主要動向には、次世代シーケンシング（NGS）技術の発展、人工知能（AI）や機械学習（ML）との統合、消費者直接（DTC）遺伝子検査の拡大、携帯型シーケンシング機器の開発、個別化医療の成長などがあります。

がんの罹患率の増加がゲノムシーケンシング市場の成長を牽引すると予想されます。がんは、異常細胞の制御不能な増殖と拡散を特徴とし、効果的に管理されなければ死に至る可能性があります。がんの発生が増加しているのは、高齢化、ライフスタイルの選択、環境暴露、遺伝的素因などの要因によるものです。ゲノムシーケンシングは、がんの遺伝子変異や素因を特定する上で重要な役割を果たし、早期発見や個人に合わせた治療計画を可能にします。遺伝性のがんリスクを明らかにし、がん細胞の開発を追跡するのに役立ちます。例えば、世界保健機関（WHO）は2024年2月、新たながん患者が2050年までに3,500万人を超えると予測し、2022年に報告された2,000万人から77％増加すると述べた。その結果、がんの発生件数の増加がゲノムシーケンシング市場の拡大に拍車をかけています。

ゲノムシーケンシング市場の主要企業は、遺伝子分析の精度を高め、個別化医療のアプローチをサポートするために、次世代シーケンサー（NGS）ベースのアッセイなどの先進ソリューションの開発に注力しています。NGSベースのアッセイは、DNAまたはRNAの迅速かつ高性能シーケンスを可能にする洗練されたゲノム技術であり、数百万のフラグメントの同時シーケンスが可能で、迅速かつコスト効率よく大量のデータを生成することができます。例えば、2023年4月、ドイツを拠点とする希少疾患の遺伝子診断プロバイダーであるCentogene N.V.は、NGSベースの強化型アッセイであるCentoGenomeを発表しました。このアッセイは、プロアクティブな診断確認と再分類プログラムによる生涯にわたる診断サポートを追加費用なしで提供し、継続的な患者ケアと正確な疾患管理を保証します。CentoGenomeはバイアスを減らし、シーケンスの質を向上させるためにPCRフリーのアプローチを採用しており、困難なゲノム領域のカバレッジを向上させ、コーディング領域、制御領域、イントロン領域に関する洞察を深めることができます。このプラットフォームは、自動化されたバイオインフォマティクス・パイプラインと医療専門家による分析を特徴としており、120カ国以上にわたる約70万人の患者から得られたセントジーンの広範なバイオデータバンクを活用しています。この包括的なデータセットは、脊髄性筋萎縮症やパーキンソン病に関連するものを含む、疾患の原因となるバリアントの検出を強化します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界のゲノムシーケンシング市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のゲノムシーケンシング市場の実績：規模と成長、2018～2023年
• 世界のゲノムシーケンシング市場の予測：規模と成長、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界のゲノムシーケンシング市場：製品別、実績と予測、2018～2023年、2023～2028年、2033年
• 消耗品
• システムとソフトウェア
• サービス
• 世界のゲノムシーケンシング市場：技術別、実績と予測、2018～2023年、2023～2028年、2033年
• ポリメラーゼ連鎖反応（PCR）
• シーケンシング
• マイクロアレイ
• 核酸抽出
• 精製
• その他
• 世界のゲノムシーケンシング市場：用途別、実績と予測、2018～2023年、2023～2028年、2033年
• 診断
• 創薬
• 精密医療
• 環境ゲノミクス
• 研究
• その他
• 世界のゲノムシーケンシング市場：エンドユーザー別、実績と予測、2018～2023年、2023～2028年、2033年
• 病院とクリニック
• バイオテクノロジーと製薬会社
• 契約研究機関（CRO）
• 政府
• 研究センター
• 学術機関と政府機関
• その他

第7章 地域別・国別分析

• 世界のゲノムシーケンシング市場：地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界のゲノムシーケンシング市場：国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ゲノムシーケンシング市場：競合情勢
• ゲノムシーケンシング市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Danaher Corporation
  • Merck KGaA

第31章 その他の大手企業と革新的企業

• Siemens Healthineers
• Becton, Dickinson and Company
• Eurofins Genomics
• Agilent Technologies Inc.
• PerkinElmer
• Illumina Inc.
• bioMerieux
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• 10x Genomics Inc.
• BGI Group
• Oxford Nanopore Technologies plc
• Pacific Biosciences of California Inc.
• GENEWIZ Inc.
• LI-COR Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的な分析

第36章 付録

Genome sequencing is the process of determining the complete DNA sequence of an organism's genome. It involves identifying the precise order of nucleotides (adenine, cytosine, guanine, and thymine) in the genome, which encompasses all of an organism's genetic material. This sequencing provides detailed information about the genetic blueprint of an organism, allowing scientists to understand genetic variations, identify mutations, and study the relationships between genes and traits or diseases.

The primary types of genome sequencing products include consumables, systems, software, and services. Consumables are single-use items required for preparing DNA samples, facilitating reactions, and capturing sequencing data, which are crucial for each step of the sequencing process to ensure accurate and efficient results. They encompass various technologies such as polymerase chain reaction (PCR), sequencing, microarray, nucleic acid extraction, and purification, among others. These products are used in a range of applications, including diagnostics, drug discovery, precision medicine, environmental genomics, and research. They are utilized by various end-users, including hospitals and clinics, biotechnology and pharmaceutical companies, contract research organizations (CROs), government and research centers, academic institutions, and others.

The genome sequencing market research report is one of a series of new reports from The Business Research Company that provides genome sequencing market statistics, including genome sequencing industry global market size, regional shares, competitors with a genome sequencing market share, detailed genome sequencing market segments, market trends, and opportunities, and any further data you may need to thrive in the genome sequencing industry. This genome sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genome sequencing market size has grown rapidly in recent years. It will grow from $8.33 billion in 2023 to $9.89 billion in 2024 at a compound annual growth rate (CAGR) of 18.7%. The growth observed in the historic period can be attributed to increased research funding, heightened awareness of personalized medicine, a rise in genomic data, expansion of clinical applications, and growing demand for biomarker discovery.

The genome sequencing market size is expected to see rapid growth in the next few years. It will grow to $19.87 billion in 2028 at a compound annual growth rate (CAGR) of 19.1%. The anticipated growth during the forecast period can be attributed to advancements in genomic research, a rise in the prevalence of genetic disorders, increasing cancer rates, integration with other omics, and growing public awareness and acceptance. Key trends expected to shape this period include advancements in next-generation sequencing (NGS) technologies, integration with artificial intelligence (AI) and machine learning (ML), expansion of direct-to-consumer (DTC) genetic testing, development of portable sequencing devices, and the growth of personalized medicine.

The increasing incidence of cancer is expected to drive the growth of the genome sequencing market. Cancer, characterized by the uncontrolled growth and spread of abnormal cells, can lead to death if not managed effectively. The rising occurrence of cancer is attributed to factors such as an aging population, lifestyle choices, environmental exposures, and genetic predispositions. Genome sequencing plays a crucial role in identifying genetic mutations and predispositions to cancer, enabling early detection and personalized treatment plans. It helps reveal inherited cancer risks and track the development of cancerous cells. For example, the World Health Organization projected in February 2024 that new cancer cases are expected to exceed 35 million by 2050, representing a 77% increase from the 20 million cases reported in 2022. Consequently, the growing occurrence of cancer is fueling the expansion of the genome sequencing market.

Leading companies in the genome sequencing market are focusing on developing advanced solutions, such as next-generation sequencing (NGS)-based assays, to enhance the accuracy of genetic analysis and support personalized medicine approaches. NGS-based assays are sophisticated genomic technologies that enable rapid and high-throughput sequencing of DNA or RNA, allowing for the simultaneous sequencing of millions of fragments and generating large volumes of data quickly and cost-effectively. For instance, in April 2023, Centogene N.V., a Germany-based provider of genetic diagnostics for rare diseases, launched CentoGenome, an enhanced NGS-based assay. This assay offers lifelong diagnostic support with proactive diagnosis confirmation and reclassification programs at no additional cost, ensuring continuous patient care and precise disease management. CentoGenome utilizes a PCR-free approach to reduce bias and improve sequencing quality, providing better coverage of challenging genomic regions and enhancing insights into coding, regulatory, and intronic areas. The platform features an automated bioinformatics pipeline and medical expert analysis, leveraging CENTOGENE's extensive bio databank of data from approximately 700,000 patients across more than 120 countries. This comprehensive dataset enhances the detection of disease-causing variants, including those associated with spinal muscular atrophy and Parkinson's disease.

In January 2023, QIAGEN N.V., a Germany-based provider of sample and assay technologies for research, acquired Verogen Inc. for an undisclosed amount. This acquisition allows QIAGEN to offer a wide range of forensic solutions based on PCR, digital PCR, and NGS technologies and to gain exclusive distribution rights. Verogen Inc., based in the US, specializes in next-generation sequencing (NGS) solutions for forensic genomics.

Major companies operating in the genome sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton, Dickinson and Company, Eurofins Genomics, Agilent Technologies Inc., PerkinElmer, Illumina Inc., bioMerieux, Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., BGI Group, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., GENEWIZ Inc., LI-COR Inc., CENTOGENE N.V., Bioneer Corporation, Strand Life Sciences Pvt Ltd., Nebula Genomics

North America was the largest region in the genome sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genome sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genome sequencing market consists of revenues earned by entities by providing services such as whole genome sequencing, targeted sequencing, and agri-genomics. The market value includes the value of related goods sold by the service provider or included within the service offering. The genome sequencing market also includes sales of reagents, automated pipettors, and genotyping kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genome Sequencing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genome sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genome sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genome sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Consumables; Systems And Software; Services
• 2) By Technology: Polymerase Chain Reaction (PCR); Sequencing; Microarray; Nucleic Acid Extraction; Purification; Other Technologies
• 3) By Applications: Diagnostics; Drug Discovery; Precision Medicine; Environmental Genomics; Research; Other Applications
• 4) By End-User: Hospitals And Clinics; Biotechnology And Pharmaceutical Companies; Contract Research Organizations (CROs); Government; Research Centers; Academic And Government Institutes; Other End-Users
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Merck KGaA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genome Sequencing Market Characteristics

3. Genome Sequencing Market Trends And Strategies

4. Genome Sequencing Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Genome Sequencing Market Size and Growth

• 5.1. Global Genome Sequencing Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Genome Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Genome Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Genome Sequencing Market Segmentation

• 6.1. Global Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Consumables
• Systems And Software
• Services
• 6.2. Global Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Polymerase Chain Reaction (PCR)
• Sequencing
• Microarray
• Nucleic Acid Extraction
• Purification
• Other Technologies
• 6.3. Global Genome Sequencing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Diagnostics
• Drug Discovery
• Precision Medicine
• Environmental Genomics
• Research
• Other Applications
• 6.4. Global Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals And Clinics
• Biotechnology And Pharmaceutical Companies
• Contract Research Organizations (CROs)
• Government
• Research Centers
• Academic And Government Institutes
• Other End-Users

7. Genome Sequencing Market Regional And Country Analysis

• 7.1. Global Genome Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Genome Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Genome Sequencing Market

• 8.1. Asia-Pacific Genome Sequencing Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Genome Sequencing Market

• 9.1. China Genome Sequencing Market Overview
• 9.2. China Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Genome Sequencing Market

• 10.1. India Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Genome Sequencing Market

• 11.1. Japan Genome Sequencing Market Overview
• 11.2. Japan Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Genome Sequencing Market

• 12.1. Australia Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Genome Sequencing Market

• 13.1. Indonesia Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Genome Sequencing Market

• 14.1. South Korea Genome Sequencing Market Overview
• 14.2. South Korea Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Genome Sequencing Market

• 15.1. Western Europe Genome Sequencing Market Overview
• 15.2. Western Europe Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Genome Sequencing Market

• 16.1. UK Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Genome Sequencing Market

• 17.1. Germany Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Genome Sequencing Market

• 18.1. France Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Genome Sequencing Market

• 19.1. Italy Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Genome Sequencing Market

• 20.1. Spain Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Genome Sequencing Market

• 21.1. Eastern Europe Genome Sequencing Market Overview
• 21.2. Eastern Europe Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Genome Sequencing Market

• 22.1. Russia Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Genome Sequencing Market

• 23.1. North America Genome Sequencing Market Overview
• 23.2. North America Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Genome Sequencing Market

• 24.1. USA Genome Sequencing Market Overview
• 24.2. USA Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Genome Sequencing Market

• 25.1. Canada Genome Sequencing Market Overview
• 25.2. Canada Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Genome Sequencing Market

• 26.1. South America Genome Sequencing Market Overview
• 26.2. South America Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Genome Sequencing Market

• 27.1. Brazil Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Genome Sequencing Market

• 28.1. Middle East Genome Sequencing Market Overview
• 28.2. Middle East Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Genome Sequencing Market

• 29.1. Africa Genome Sequencing Market Overview
• 29.2. Africa Genome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Genome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Genome Sequencing Market Competitive Landscape And Company Profiles

• 30.1. Genome Sequencing Market Competitive Landscape
• 30.2. Genome Sequencing Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Thermo Fisher Scientific Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Abbott Laboratories
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Danaher Corporation
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Merck KGaA
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Genome Sequencing Market Other Major And Innovative Companies

• 31.1. Siemens Healthineers
• 31.2. Becton, Dickinson and Company
• 31.3. Eurofins Genomics
• 31.4. Agilent Technologies Inc.
• 31.5. PerkinElmer
• 31.6. Illumina Inc.
• 31.7. bioMerieux
• 31.8. Bio-Rad Laboratories Inc.
• 31.9. QIAGEN N.V.
• 31.10. 10x Genomics Inc.
• 31.11. BGI Group
• 31.12. Oxford Nanopore Technologies plc
• 31.13. Pacific Biosciences of California Inc.
• 31.14. GENEWIZ Inc.
• 31.15. LI-COR Inc.

32. Global Genome Sequencing Market Competitive Benchmarking

33. Global Genome Sequencing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Genome Sequencing Market

35. Genome Sequencing Market Future Outlook and Potential Analysis

• 35.1 Genome Sequencing Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Genome Sequencing Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Genome Sequencing Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer